Echo Therapeutics
Iselin, US · Delaware corporation
Founders & leadership
SW
Scott W. HollanderExecutive
AS
Alan SchoenbartExecutive
Board
MM
Michael M. GoldbergBoard director
ER
Elazer R. EdelmanBoard director
SG
Shepard GoldbergBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2016
▶$1.8MraisedFeb 2016 · 15 investors · BiotechnologyRule 506(b)
▶$1.8MraisedFeb 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott W. HollanderExecutive Officer, Director
- Alan SchoenbartExecutive Officer
- Michael M. GoldbergDirector
- Elazer R. EdelmanDirector
- Shepard GoldbergDirector
- Offering amount
- $6M
- Amount sold
- $1.8M
- Minimum investment
- $50K
- Sales commissions
- $145.5K
- Proceeds to insiders
- $200K
- Placement agents
- Newbridge Securities Corporation
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Echo Therapeutics Inc, one in a String of Platinum Decimated Companies…. Answering Some Questions. | LOSTMESSIAHlostmessiahdotcom.wordpress.com · Apr 2017Frequently asked questions
- How much funding has Echo Therapeutics raised?
- Echo Therapeutics has disclosed $1.8M raised across 1 round.
- Where is Echo Therapeutics headquartered?
- Echo Therapeutics is headquartered in Iselin, US.